Optimized Catheter System Demonstrates Utility for Endomyocardial Delivery of Cardiopoietic Stem Cells in Target Patients With Heart Failure

Tex Heart Inst J. 2023 Oct 23;50(5):e238247. doi: 10.14503/THIJ-23-8247.

Authors

Jozef Bartunek¹, Andre Terzic²

Affiliations

¹ Cardiovascular Center, Onze-Lieve-Vrouwziekenhuis Hospital, Aalst, Belgium.
² Marriott Heart Disease Research Program, Center for Regenerative Medicine and Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

No abstract available

Keywords: Catheter; clinical trial; heart failure; myocardium; regenerative medicine; stem cells.

MeSH terms

Heart Failure* / diagnosis
Heart Failure* / therapy
Humans
Myocardium
Stem Cells

Grants and funding

Funding/Support: Work at the Mayo Clinic is supported by the Marriott Foundation.